Quest, Hologic Enter Deal to Improve Women's Health | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics and Hologic today announced an alliance aimed at improving women's health.

Under the terms of the five-year strategic alliance, Quest will more broadly offer testing based on Hologic's Aptima products. The two firms will also co-develop and promote advanced diagnostics solutions for women's health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.